GV 2021, L.P., 10% Owner at Prime Medicine, Inc. (PRME), sold 116,298 shares at $12.77 ($1.5M) on 2023-05-17, disclosed to the SEC on 2023-05-18.
Scheduled sale ($1.5M) by 10% Owner under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $12.59 | 50,649 | $638K | 43.5% |
| 2 | $12.59 | 50,649 | $638K | 43.5% |
| 3 | $12.77 | 15,000 | $192K | 13.1% |
| Total | $12.61 avg | 116,298 | $1.5M | 100% |
| Filing → |
| PRME | BUY | 2022-10-26 | $13.6M | — | Filing → |
| GTLB | BUY | 2022-05-16 | $1.6M | — | Filing → |